Delivery Order SPE2DB22D3016-SPE2DB25FAHZ7

Award Date 1/2/25
Potential Completion Date 1/24/25
Potential Value $5.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,916.78 firm fixed price delivery order contract is for the supply of PHESGO 600-600 MG-20,000 unit 10ML, a medical product. The contract has a completion date of January 27, 2025 and was awarded on January 3, 2025. The award is not associated with a set-aside designation. AmerisourceBergen Drug Corp holds a...
This federal contract award, SPE2DB22D3016|SPE2DB25FAAB9, was issued by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corp Corporate Office Division. The $10,641.84 firm fixed-price delivery order is for the pharmaceutical product PHESGO 600-600 MG-20,000 UNIT 10ML. The contract has an ultimate completion date of October 29, 2024 and was awarded on October 7, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This federal contract award, valued at $5,458.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of PHESGO 600-600 MG-20,000 UNIT 10ML medical products, which are likely pharmaceutical or medical supply items. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $11,009.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of PHESGO 600-600 MG-20,000 UNIT 10ML, a pharmaceutical product, with a completion date of December 27, 2024. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $75,025.02, is a Firm Fixed Price Delivery Order for the supply of PHESGO 600-600MG 1S, a pharmaceutical product. The contract has a period of performance through March 29, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,458.39 firm fixed-price contract is for the supply of PHESGO 600-600 MG-20,000 UNIT 10ML, a pharmaceutical product. The contract has a period of performance through March 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of 4,564,376,730 units of the pharmaceutical product PHESGO (1,200-600MG-30,000 unit, 15ML) at a ceiling value of $8,159.16. The contract has a firm fixed price pricing type and an ultimate completion date of May 14, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,833.56, is for the supply of PHESGO 600-600 MG-20,000 UNIT 10ML medical products. The contract is a firm fixed-price delivery order with an ultimate completion date of February 18, 2025. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen...
This federal contract award, valued at $10,641.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of PHESGO, a medical product, with a completion date of October 7, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) vehicle between Amerisourcebergen and the DLA, potentially worth up to $999,999,999, for the supply of a broad range of medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PHESGO 600-600 MG-20,000 UNIT 10ML, a pharmaceutical product, with a ceiling value of $5,504.81 and a period of performance through January 17, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating it was competed openly....
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAHZ7
    Delivery Order

The federal contract award SPE2DB22D3016|SPE2DB25FAHZ7 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,458.39 firm fixed-price delivery order covers the supply of PHESGO 600-600 MG-20,000 UNIT 10ML, a medical product, with a period of performance through January 24, 2025. This contract award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/3/25, 10:47 AM